Moderna Inc said on Monday
PHOTO
Moderna Inc said on Monday it will supply 12 million doses of its variant-adapted COVID-19 shot that targets the Omicron version of the coronavirus to Canada.
Moderna in June said trial data showed that when given as a fourth dose, the variant-adapted shot raised virus-neutralizing antibodies by eight-fold against Omicron. (Reporting by Mrinalika Roy in Bengaluru; Editing by Shailesh Kuber)
Reuters
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
© ZAWYA 2024
